Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Endovascular Development AB
AB
Bankrupt
Org 5567830673
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2009 · 17 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Endovascular Development AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2018: 0M
0M
2018
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
EBITDA
SEK millions
0M
-1M
-1M
-2M
-2M
2018: -2M
-2M
2018
2019: -2M (0% vs 2018)
-2M
0%
2019
2020: -2M (0% vs 2019)
-2M
0%
2020
2021: 0M (+100% vs 2020)
0M
2021
2022: 0M
0M
2022
Income statement
SEK thousands
Item
2022
2021
2020
2019
2018
Revenue
0
31
229
0
7
Staff expenses
−0
—
—
—
—
EBITDA
−93
−161
−2 220
−2 036
−1 608
Depreciation & amort.
−532
−4 136
−1 024
−1 033
−1 033
EBIT
−625
−4 297
−3 244
−3 069
−2 641
Net financials
−152
−84
−47
−2
−1
Profit before tax
−777
−4 381
−3 292
−3 071
−2 642
Tax
—
−0
−0
−0
−0
Net profit
−777
−4 381
−3 292
−3 071
−2 642
Balance sheet
SEK thousands
Item
2022
2021
2020
2019
2018
Total assets
1 465
2 036
7 042
7 295
8 125
Equity
190
731
5 112
6 404
7 475
Long-term debt
1 275
1 283
1 200
250
150
Short-term debt
0
21
729
641
500
Total debt
1 275
1 304
1 929
891
650
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2018
2022
Equity ratio
12,9 %
This company
38,2 %
Market median
This company
Market median
66% below market
2018
2022
Return on equity
−409,7 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2018
2022
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2018
2022
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2018
2022
Debt / equity
6,72×
This company
0,62×
Market median
This company
Market median
984% above market
2018
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
More on Endovascular Development AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
